Ann Dermatol.  2019 Aug;31(Suppl):S1-S2. 10.5021/ad.2019.31.S.S1.

A Case Report of Hailey–Hailey Disease Treated with Alitretinoin

• Park AY
• Lee HJ
• Chung EH
• Kim JE
• Lee JS
• Lee SH
• Lee SY

• KMID: 2456657
• DOI: http://doi.org/10.5021/ad.2019.31.S.S1

Abstract

No abstract available.

Reference

1. Mayuzumi N, Ikeda S, Kawada H, Ogawa H. Effects of drugs and anticytokine antibodies on expression of ATP2A2 and ATP2C1 in cultured normal human keratinocytes. Br J Dermatol. 2005; 152:920–924.

2. Barnstedt SE. [Successful treatment of Darier disease with oral alitretinoin]. Hautarzt. 2012; 63:139–141. German.

3. Shreberk-Hassidim R, Sheffer S, Horev L, Zlotogorski A, Ramot Y. Successful treatment of refractory Darier disease with alitretinoin with a follow up of over a year: a case report. Dermatol Ther. 2016; 29:222–223.

4. Vanderbeck KA, Giroux L, Murugan NJ, Karbowski LM. Combined therapeutic use of oral alitretinoin and narrowband ultraviolet-B therapy in the treatment of hailey-hailey disease. Dermatol Reports. 2014; 6:5604.

5. Sárdy M, Ruzicka T. Successful therapy of refractory Hailey-Hailey disease with oral alitretinoin. Br J Dermatol. 2014; 170:209–211.